Trace elements in glucometabolic disorders: an update

<p>Abstract</p> <p>Many trace elements, among which metals, are indispensable for proper functioning of a myriad of biochemical reactions, more particularly as enzyme cofactors. This is particularly true for the vast set of processes involved in regulation of glucose homeostasis, b...

Full description

Bibliographic Details
Main Authors: Wiernsperger Nicolas, Rapin JeanRobert
Format: Article
Language:English
Published: BMC 2010-12-01
Series:Diabetology & Metabolic Syndrome
Online Access:http://www.dmsjournal.com/content/2/1/70
id doaj-0f1a7c07559d455f88612875c021f0fa
record_format Article
spelling doaj-0f1a7c07559d455f88612875c021f0fa2020-11-24T20:56:53ZengBMCDiabetology & Metabolic Syndrome1758-59962010-12-01217010.1186/1758-5996-2-70Trace elements in glucometabolic disorders: an updateWiernsperger NicolasRapin JeanRobert<p>Abstract</p> <p>Many trace elements, among which metals, are indispensable for proper functioning of a myriad of biochemical reactions, more particularly as enzyme cofactors. This is particularly true for the vast set of processes involved in regulation of glucose homeostasis, being it in glucose metabolism itself or in hormonal control, especially insulin. The role and importance of trace elements such as chromium, zinc, selenium, lithium and vanadium are much less evident and subjected to chronic debate. This review updates our actual knowledge concerning these five trace elements. A careful survey of the literature shows that while theoretical postulates from some key roles of these elements had led to real hopes for therapy of insulin resistance and diabetes, the limited experience based on available data indicates that beneficial effects and use of most of them are subjected to caution, given the narrow window between safe and unsafe doses. Clear therapeutic benefit in these pathologies is presently doubtful but some data indicate that these metals may have a clinical interest in patients presenting deficiencies in individual metal levels. The same holds true for an association of some trace elements such as chromium or zinc with oral antidiabetics. However, this area is essentially unexplored in adequate clinical trials, which are worth being performed.</p> http://www.dmsjournal.com/content/2/1/70
collection DOAJ
language English
format Article
sources DOAJ
author Wiernsperger Nicolas
Rapin JeanRobert
spellingShingle Wiernsperger Nicolas
Rapin JeanRobert
Trace elements in glucometabolic disorders: an update
Diabetology & Metabolic Syndrome
author_facet Wiernsperger Nicolas
Rapin JeanRobert
author_sort Wiernsperger Nicolas
title Trace elements in glucometabolic disorders: an update
title_short Trace elements in glucometabolic disorders: an update
title_full Trace elements in glucometabolic disorders: an update
title_fullStr Trace elements in glucometabolic disorders: an update
title_full_unstemmed Trace elements in glucometabolic disorders: an update
title_sort trace elements in glucometabolic disorders: an update
publisher BMC
series Diabetology & Metabolic Syndrome
issn 1758-5996
publishDate 2010-12-01
description <p>Abstract</p> <p>Many trace elements, among which metals, are indispensable for proper functioning of a myriad of biochemical reactions, more particularly as enzyme cofactors. This is particularly true for the vast set of processes involved in regulation of glucose homeostasis, being it in glucose metabolism itself or in hormonal control, especially insulin. The role and importance of trace elements such as chromium, zinc, selenium, lithium and vanadium are much less evident and subjected to chronic debate. This review updates our actual knowledge concerning these five trace elements. A careful survey of the literature shows that while theoretical postulates from some key roles of these elements had led to real hopes for therapy of insulin resistance and diabetes, the limited experience based on available data indicates that beneficial effects and use of most of them are subjected to caution, given the narrow window between safe and unsafe doses. Clear therapeutic benefit in these pathologies is presently doubtful but some data indicate that these metals may have a clinical interest in patients presenting deficiencies in individual metal levels. The same holds true for an association of some trace elements such as chromium or zinc with oral antidiabetics. However, this area is essentially unexplored in adequate clinical trials, which are worth being performed.</p>
url http://www.dmsjournal.com/content/2/1/70
work_keys_str_mv AT wiernspergernicolas traceelementsinglucometabolicdisordersanupdate
AT rapinjeanrobert traceelementsinglucometabolicdisordersanupdate
_version_ 1716789424934617088